Business Description
Aurora Cannabis Inc
NAICS : 325410
SIC : 3741
ISIN : CA05156X8843
Total Employee Number:
1,101Compare
Compare
Traded in other countries / regions
ACB.CanadaACB.USA21P.Germany21P.Bulgaria0UJG.UK IPO Date
2014-07-10Description
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.9 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.61 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -12.42 | |||||
Beneish M-Score | -2.94 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18.1 | |||||
3-Year EBITDA Growth Rate | 78.5 | |||||
3-Year EPS without NRI Growth Rate | 59.7 | |||||
3-Year FCF Growth Rate | 54.2 | |||||
3-Year Book Growth Rate | -26.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.83 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.08 | |||||
9-Day RSI | 30.84 | |||||
14-Day RSI | 33.26 | |||||
3-1 Month Momentum % | 3.59 | |||||
6-1 Month Momentum % | -22.94 | |||||
12-1 Month Momentum % | -18.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.94 | |||||
Quick Ratio | 3.32 | |||||
Cash Ratio | 1.75 | |||||
Days Inventory | 434.55 | |||||
Days Sales Outstanding | 47.14 | |||||
Days Payable | 93.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.6 | |||||
Shareholder Yield % | 3.8 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.62 | |||||
Operating Margin % | -14.46 | |||||
Net Margin % | -42.41 | |||||
EBITDA Margin % | -12.27 | |||||
FCF Margin % | -11.17 | |||||
OCF Margin % | -4.14 | |||||
ROE % | -25.19 | |||||
ROA % | -17.78 | |||||
ROIC % | -8.08 | |||||
3-Year ROIIC % | -116.09 | |||||
ROC (Joel Greenblatt) % | -11.36 | |||||
ROCE % | -8.5 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 83.24 | |||||
PS Ratio | 0.72 | |||||
PB Ratio | 0.47 | |||||
Price-to-Tangible-Book | 0.53 | |||||
EV-to-EBIT | -2.88 | |||||
EV-to-EBITDA | -4.01 | |||||
EV-to-Forward-EBITDA | 38.81 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-Forward-Revenue | 0.54 | |||||
EV-to-FCF | -4.38 | |||||
Price-to-GF-Value | 0.68 | |||||
Price-to-Median-PS-Value | 0.15 | |||||
| Price-to-Net-Current-Asset-Value | 0.77 | |||||
| Price-to-Net-Cash | 8.61 | |||||
Earnings Yield (Greenblatt) % | -34.72 | |||||
FCF Yield % | -14.37 |
Aurora Cannabis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aurora Cannabis Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-05 08:00 | In 130 days | ||
| Second quarter earnings results for 2027 | 2026-11-05 | In 129 days | ||
| General meeting for 2026 | 2026-08-07 13:00 | In 40 days | ||
| First quarter earnings conference call for 2027 | 2026-08-06 08:00 | In 39 days | ||
| First quarter earnings results for 2027 | 2026-08-06 | In 38 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-06-11 08:00 | 3.29 (-1.50%) | ||
| Annual report for 2026 | 2026-06-11 | 3.29 (-1.50%) | ||
| Fourth quarter earnings results for 2026 | 2026-06-11 | 3.29 (-1.50%) | ||
| Aurora to Participate in the TD Cowen 46th Annual Health Care Conference | 2026-03-02 11:10 | 3.84 (-0.52%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-04 08:00 | 4.06 (+2.78%) |
Show
Entries
Guru Commentaries on NAS:ACB
No articles.
Press Release
Articles on Aurora Cannabis Inc
No articles.
Headlines
See More- 1
Jun 11, 2026
Aurora Cannabis dips after projecting a revenue decline for FY27
Seeking Alpha • 7:15am
Aurora Cannabis reports Q4 results
Seeking Alpha • 6:07am
Jun 10, 2026
Here are the major earnings before the open Thursday
Seeking Alpha • 5:00pm
Aurora Cannabis Q4 earnings on deck: Here's what to expect
Seeking Alpha • 10:08am
Jun 07, 2026
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers